Clinical Trials


Now enrolling...The use of an investigational drug (SA237) for Neuromyelitis Optica (NMO)

Posted March 17, 2016 by Jeneane Nichol Henry

Now enrolling individuals with Neuromyelitis Optica (NMO) or Neuromyelitis Optica Spectrum Disorder (NMOSD) for a clinical trial testing an investigational drug called SA237

...Read More

Not open to enrollment... The use of Plegridy (PEGylated interferon beta-1a) in patients with Multiple Sclerosis (POP Study)

Posted March 17, 2016 by Jeneane Nichol Henry

The purpose of this open-labeled, observational study is to provide long-term effectiveness and safety data in patients with relapsing forms of MS who have been prescribed Plegridy in routine clinical practice.

...Read More

Now Enrolling......The use of Tecfidera (Dimethyl Fumarate) in patients with Multiple Sclerosis (Esteem Study)

Posted March 25, 2016 by Jeneane Nichol Henry

The purpose of this study is to better characterize the long-term benefit-risk profile of Tecfidera (Dimethyl Fumarate) in patients with multiple sclerosis (MS) who are prescribed Tecfidera under routine clinical care.

...Read More